Alessandro Rambaldi
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.01%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 475
- Acute Myeloid Leukemia Research 247
- Chronic Myeloid Leukemia Treatments 158
- Hematopoietic Stem Cell Transplantation 139
- Genetics 375
- Myeloproliferative Neoplasms: Diagnosis and Treatment 210
- Chronic Lymphocytic Leukemia Research 129
- Co-authors
- Tiziano Barbui (191 shared papers)Martino Introna (79 shared papers)Josée Golay (68 shared papers)Alessandro Maria Vannucchi (81 shared papers)Andrea Biondi (60 shared papers)Guido Finazzi (49 shared papers)Alessandra Carobbio (48 shared papers)Paola Guglielmelli (35 shared papers)
- Journals
- Blood (270 papers)Bone Marrow Transplantation (44 papers)Leukemia (44 papers)Haematologica (41 papers)American Journal of Hematology (38 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Alessandro Rambaldi
921 papers receiving 47.8k citations
Alessandro Rambaldi's Hit Papers
Peers
Comparison fields: 5 of 170
- Hematology 20.4k
- Genetics 16.8k
- Oncology 11.4k
- Pathology and Forensic Medicine 7.2k
- Immunology 7.1k
Countries citing papers authored by Alessandro Rambaldi
This map shows the geographic impact of Alessandro Rambaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Rambaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Rambaldi more than expected).
Fields of papers citing papers by Alessandro Rambaldi
This network shows the impact of papers produced by Alessandro Rambaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Rambaldi. The network helps show where Alessandro Rambaldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessandro Rambaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 951 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma Hit paper breakdown → | 2021 | 1948 |
| 2 | Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia Hit paper breakdown → | 2017 | 1693 |
| 3 | Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Hit paper breakdown → | 2013 | 1262 |
| 4 | Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study Hit paper breakdown → | 2014 | 1068 |
| 5 | Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease Hit paper breakdown → | 1999 | 995 |
| 6 | Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis Hit paper breakdown → | 2014 | 573 |
| 7 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2018 | 554 |
| 8 | Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study Hit paper breakdown → | 2013 | 543 |
| 9 | 2000 | 503 | |
| 10 | Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) Hit paper breakdown → | 2012 | 476 |
| 11 | PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Hit paper breakdown → | 2019 | 450 |
| 12 | 1992 | 412 | |
| 13 | MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis Hit paper breakdown → | 2017 | 408 |
| 14 | 2007 | 378 | |
| 15 | Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults Hit paper breakdown → | 2020 | 378 |
| 16 | 2009 | 370 | |
| 17 | 2001 | 368 | |
| 18 | 2012 | 360 | |
| 19 | Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study Hit paper breakdown → | 2017 | 358 |
| 20 | High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults Hit paper breakdown → | 2017 | 348 |
About Alessandro Rambaldi
Alessandro Rambaldi is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Immunology, having authored 951 papers that have together received 49.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (247 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (210 papers), Acute Lymphoblastic Leukemia research (176 papers), Chronic Myeloid Leukemia Treatments (158 papers), Lymphoma Diagnosis and Treatment (153 papers), Hematopoietic Stem Cell Transplantation (139 papers), Chronic Lymphocytic Leukemia Research (129 papers) and Eosinophilic Disorders and Syndromes (87 papers). The work is most often cited by research in Hematology (20.4k citations), Genetics (16.8k citations), Oncology (11.4k citations), Pathology and Forensic Medicine (7.2k citations) and Immunology (7.1k citations). Alessandro Rambaldi has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Tiziano Barbui, Martino Introna, Josée Golay, Alessandro Maria Vannucchi, Andrea Biondi, Guido Finazzi, Alessandra Carobbio, Paola Guglielmelli, Gianmaria Borleri and Renato Bassan. Their work appears in journals such as Blood, Bone Marrow Transplantation, Leukemia, Haematologica and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.